Pre-Conference Symposium

pdf Download PDF

10th Pharmaceutical Care Conference & Exhibition

Pre-conference Symposium Tuesday 17 March 2020

 

Type of session: knowledge – based 

Countries Initiatives to Meet the WHO 3rd Global Patient Safety Challenge

“Medication without Harm

@ Auditorium    

Moderator: David Cousins

Time

Speaker

Topic

09:00-09:15

Qamra Al-Sarari

Director General of Quality Assurance Center

Key note and Introduction

09:15-09:35

Mondher Letaief, MD, MPH

Regional Adviser, Quality and Safety

Department of Universal Health Coverage Health Systems World Health Organization – EMRO

Updates on the WHO Patient Safety Global Challenge: "Medication without Harm"

 

09:35-09:50

Lina R. Bader PhD RPharmS Lead for Workforce Transformation & Development at International Pharmaceutical Federation (FIP)

Patient & Medication Safety: Pharmacists’ Perspective and Contribution

09:50-10:10

Sara Albalushi

Director pharmaceutical Care. MOH.Oman

Ministry of Health Response to Medication without Harm Challenge

“Pharmaceutical Care Initiatives”  

10:10-10:40

Coffee break

10:40-11:00

Thamir Alshamari PhD Medication Safety Research Chair Pharmacovigilance and Drug Safety Consultant Advisor, Executive president, Saudi Food and Drug Authority (SFDA)

Medication without harm: Saudi Arabia Experiences

11:00-11:20

Mohammed Alshennawi, B.Sc. Pharm., M.B.A. General Director, General Administration of Pharmaceutical Care, Ministry of Health, Riyadh, Saudi Arabia.

Shifting Toward Safety Culture – The Saudi Ministry of Health  Experience

 

11:20-11:40

Alpana Mair FFRPS,IP, MRPharmS

Head of Effective Prescribing and Therapeutics, Scottish Government Scottish Quality, Safety & Improvement Fellow.UK

Addressing Medication Safety in Polypharmacy and High Risk Medications

11:40-12:00

Charlotte Rossing, M Sc (Pharm), PhD.

Director of R&D, Pharmakon, Danish College of Pharmacy Practice. Denmark

 

Danish Initiatives to Support WHO Initiative “Medication Without Harm” and How to Measure if Success

12:00-12:20

Carolyn Hoffman RN MN
President and CEO Institute for Safe Medication Practices Canada(ISMP Canada) System. Canada

Responding to the WHO Global Challenge: Reporting, Learning and Engaging to Improve Medication Safety in Canada

12:20-12:40

John B. Hertig, Pharm.D., M.S., CPPS, FASHP Vice-Chair and Associate Professor Department of Pharmacy Practice Butler University College of Pharmacy and Health Sciences. USA

High-Risk but no Harm: USA Strategies for Using Human Factors Science to Improve Patient Safety.

12:40-13:00

Chris Campbell president of the Pharmaceutical Society of Australia Queensland Branch and the professional practice manager for the Terry White Chemmart Group. Australia

Advances in Medicines Safety Research in Australia – Medicines Safety the 10th National Health Priority Area                                        

13:00-13:20

Ciara Kirke

Clinical Lead, National Medication Safety Program, Health Service Executive, Ireland

Partnering with People Using Medicines – the key to Ireland’s Response to the Medication Without Harm Challenge

13:20-13:50

Discussion

13:50-14:50

Lunch